1,008
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer

, , , , , , , , , , , , , & show all
Article: e1038017 | Received 03 Mar 2015, Accepted 01 Apr 2015, Published online: 27 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Qiu-Zhong Pan, Jing-Jing Zhao, Chao-Pin Yang, Yu-Qing Zhou, Jun-Zhong Lin, Yan Tang, Jia-Mei Gu, Qi-Jing Wang, Yong-Qiang Li, Jia He, Shi-Ping Chen, Meng-Jia Song, Yue Huang, Jie-Ying Yang, De-Sheng Weng & Jian-Chuan Xia. (2020) Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection. OncoImmunology 9:1.
Read now
Chang-Long Chen, Qiu-Zhong Pan, De-Sheng Weng, Chuan-Miao Xie, Jing-Jing Zhao, Min-Shan Chen, Rui-Qing Peng, Dan-Dan Li, Ying Wang, Yan Tang, Qi-Jing Wang, Zhi-Ling Zhang, Xiao-Fei Zhang, Li-Juan Jiang, Zi-Qi Zhou, Qian Zhu, Jia He, Yuan Liu, Fang-Jian Zhou & Jian-Chuan Xia. (2018) Safety and activity of PD-1 blockade-activated DC-CIK cells in patients with advanced solid tumors. OncoImmunology 7:4.
Read now

Articles from other publishers (10)

Sally Esmail & Wayne R. Danter. (2021) Stem‐cell based, machine learning approach for optimizing natural killer cell‐based personalized immunotherapy for high‐grade ovarian cancer. The FEBS Journal 289:4, pages 985-998.
Crossref
Xiao Li, Haodong Zhou, Wenwen Huang, Xuejuan Wang, Mingyao Meng, Zongliu Hou, Liwei Liao, Weiwei Tang, Yanhua Xie, Ruotian Wang, Haidong Yu, Liqiong Wang, Huirong Zhu, Wenju Wang, Jing Tan & Ruhong Li. (2022) Retrospective analysis of the efficacy of adjuvant cytokine‐induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery. Clinical & Translational Immunology 11:1.
Crossref
Qiu-Zhong Pan, Qing Liu, Yu-Qing Zhou, Jing-Jing Zhao, Qi-Jing Wang, Yong-Qiang Li, Yan Tang, Jia-Mei Gu, Jia He, Shi-Ping Chen, De-Sheng Weng & Jian-Chuan Xia. (2020) CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma. Cancer Immunology, Immunotherapy 69:5, pages 825-834.
Crossref
Le Van Manh Hung, Hieu Trong Ngo & Phuc Van Pham. 2020. Cancer Biology and Advances in Treatment. Cancer Biology and Advances in Treatment 113 130 .
Qiu‐Zhong Pan, Jia‐Mei Gu, Jing‐Jing Zhao, Yan Tang, Qi‐Jing Wang, Qian Zhu, Meng‐Jia Song, Yong‐Qiang Li, Jia He, Shi‐Ping Chen, De‐Sheng Weng & Jian‐Chuan Xia. (2020) Retrospective analysis of the efficacy of cytokine‐induced killer cell immunotherapy combined with first‐line chemotherapy in patients with metastatic colorectal cancer. Clinical & Translational Immunology 9:2.
Crossref
Chuanjiang Ma, Yongli Wei, Qing Liu, Yizhou Xin, Guangshang Cao, Xin Wang & Peimin Yang. (2019) Polysaccharides from Hedyotis diffusa enhance the antitumor activities of cytokine-induced killer cells. Biomedicine & Pharmacotherapy 117, pages 109167.
Crossref
Li-Wu Fu, Yong Chen & Shao-Bo Liang. 2019. Single-Cell Omics. Single-Cell Omics 237 252 .
Yanming Sun, Zhitao Yao, Zhihua Zhao, Haifeng Xiao, Xia Mengting, Zhu Xiaojun, Jiang Xuelu & Chuntao Sun. (2018) Natural killer cells inhibit metastasis of ovarian carcinoma cells and show therapeutic effects in a murine model of ovarian cancer. Experimental and Therapeutic Medicine.
Crossref
Yuanlong Gu, Huimin Lv, Juan Zhao, Qi Li, Guannan Mu, Jiade Li, Jiazi Wuyang, Ge Lou, Ruitao Wang, Yanqiao Zhang & Xiaoyi Huang. (2017) Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC). International Immunopharmacology 50, pages 263-269.
Crossref
Sebastian Lundgren, Carl Fredrik Warfvinge, Jacob Elebro, Margareta Heby, Björn Nodin, Agnieszka Krzyzanowska, Anders Bjartell, Karin Leandersson, Jakob Eberhard & Karin Jirström. (2016) The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant Treatment. PLOS ONE 11:6, pages e0156497.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.